Your launch plan rests on answers from 300 cancer doctors. At least, that’s what the data says. But you’ve never seen how anyone checked that they’re real.
Here’s the short answer. A reliable healthcare research panel checks identity and licence when members join. It checks them again over time. It tests answers inside every survey. And it can show you proof that each check took place.
At Insights Opinion, health is one of our three core research areas. We run studies in 100+ countries and 60+ languages. Our work follows ISO 20252 for research quality and ISO 27001 for data security. We also follow GDPR and CCPA aligned practices.
Below, you’ll find the checks that matter most and makes healthcare research panel reliable. You’ll also get a short list of questions you can put to any panel provider before you sign.
It works in layers. First, who the person is. Then, what they’re trained to do. After that, repeat checks for as long as they stay on the panel.
Insights Opinion runs layered checks like these across its panels. Each one sits inside our ISO 20252 process.
Sign-up checks prove who joined. In-survey checks prove who’s answering today. They also show if people are paying attention.
The risk is real. A JMIR review of 13 studies found that 13% to 97% of survey answers were fake. Across all of them, the share was 61%. The same paper notes that open links carry more risk. An open link is a survey link anyone can find and use. A managed panel sends unique links to known members. That cuts the risk. It doesn’t remove it.
That’s why each healthcare survey needs its own checks:
These sit on top of the usual online checks, such as bot and speed checks. We cover those in our guide to CAWI survey costs.
Yes. In healthcare qualitative market research, samples are small. So one wrong person can sway the whole study.
That’s why qualitative work adds a human checkpoint. A recruiter re-screens each person by phone before booking. When the session starts, the moderator checks ID again. In-depth interviews (IDIs) and focus group discussions (FGDs) also need an articulation check. That’s a quick test of whether someone can explain their views clearly. A real expert who can’t put thoughts into words won’t help much either.
A tight recruitment brief makes all of this easier. It spells out exactly who qualifies, so there’s less room for guesswork. Our healthcare research team builds these checks into each study like this.
No. Treat a promise of zero fraud as a warning sign, not a selling point.
Fraud keeps changing, and no set of checks catches it all. What checks do is cut the risk a lot. They also help you find and remove bad data before it shapes a decision.
Here’s what happens when bad data stays in. One JMIR study received 646 valid records and 905 fraudulent ones from bot attacks. Leaving the fake data in would have changed the results in a big way.
So don’t ask for a guarantee. Ask for evidence instead:
That leads to the next question. If nothing is foolproof, what can you actually rely on?
Audited standards and written records. They turn “we check” into something you can confirm.
ISO 20252 is the global standard for market research quality. Outside auditors check the research process against it. ISO 27001 does the same for data security. Together, they show that checks are part of a system. They’re not a one-off effort.
Ask for project-level records too. A good provider can show which checks ran and what they found.
Industry codes set the bar as well. EPHMRA is the European body for pharma market research. Its 2025 Code of Conduct says research must be accurate, open and fair. It must also be of good quality. It’s also worth asking whether the team is trained to report adverse events. An adverse event is a side effect or drug problem someone mentions during research. That training shows a provider is set up for pharma work.
Ask every provider the same questions, and get the answers in writing. These best practices for researchers make it easy to compare panels side by side.
Clear answers are a good sign. Vague ones aren’t. Strong healthcare panels answer all seven with ease. That’s how healthcare market research ends up resting on people who are who they say they are. You can see how our healthcare panels handle each point.
A reliable healthcare research panel doesn’t ask for blind trust. It shows its checks, from licence matching to in-survey traps. It also gives you records to prove they ran. Put the seven questions above to any provider on your list.
Planning healthcare market research with doctors, nurses or patients? Talk to the Insights Opinion about how we verify healthcare respondents for your next project. Email us at bids@insightsopinion.com.
No. Each country has its own licence registers and data rules. A global panel needs local checks in every market, not one process for all.
They’re harder to find than to check. Because they’re scarce, fake sign-ups target them more. Extra care at screening pays off.
They’re taken out of the data. Most times, they’re swapped for fresh, valid ones. Repeat offenders should be taken off the panel.
Usually, yes. Opt-in members have agreed to take part, and they’ve been checked. A bought list gives you contact details. It doesn’t prove who will answer.
Yes. A real doctor can still rush or lose focus. That’s why in-survey checks matter as much as sign-up checks.
Not on size alone. A smaller panel with strict checks can be more reliable than a large one with weak checks. Ask how members are verified, not just how many there are.
Blogs